1.Nakashima M, Morita J, Aizawa K. Pharamacokinetics and safety of
tebipenem pivoxil fine granules, an oral carbapenem antibiotic, in
healthy male volunteers. Jpn J Chemother. 2009;57(S–1):90–94
2.Baba S, Yamanaka N, Suzuki K, et al. Clinical efficacy, safety
and PK-PD analysis of tebipenem pivoxil in a phase II clinical
trial in otolaryngological infections. Jpn J Antibiot.
2009;62:155–177
3.Sunakawa K. Pharmacological properties and clinical performance
of the novel oral carbapenem antimicrobial drug, “Tebipenem
pivoxil” (Orapenem fine granules 10% for pediatric use). Jpn J
Chemother. 2009;57:279–294
4.Yamanaka N, Furukawa M, Furuya, et al. Clinical efficacy of
tebipenem pivoxil (ME1211), a novel oral carbapenem, in otolaryngological
infections, a Phase II clinical trial (1). 45th Intersci
Conf Antimicrob Agents Chemother (ICAAC) 2005; Abstract
L-577
5.Iwata S, Ouchi K, Iwata N, et al. An open clinical study of tebipenem
pivoxil in children with bacterial pneumonia. Jpn J Chemother.
2009;57(S–1):137–150
[更多]
渝公網(wǎng)安備 50010802001068號(hào)
